OrthoPediatrics Corp. Common Stock (KIDS) — Analysis Summary
OrthoPediatrics Corp. Common Stock (KIDS) has a market cap of $484.68M with year-over-year revenue growth of +15.4%. Net margin stands at -16.8%. The stock trades at a P/E ratio of -12.2.
Key Takeaways
- Revenue changed +15.4% year-over-year
- Net margin of -16.8%
- P/E ratio of -12.2
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, KIDS posted revenue growth of +15.4% and trades at a P/E of -12.2.
OrthoPediatrics Corp. Common Stock (KIDS)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -5.2x — earnings do not cover interest payments
Operating margin at -15.0% — material operating losses
The latest filing shows negative free cash flow.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
602
Headquarters
WARSAW, IN
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.